How does psoriasis affect quality of life? Assessing an Ingram-regimen outpatient programme and validating the WHOQOL-100

British Journal of Dermatology

Volumn 154, Issue 4, 2006, Pages 680-691

  Skevington, S M ^a   Bradshaw, J ^a   Hepplewhite, A ^b   Dawkes, K ^b   Lovell, C R ^b  

^a University of Bath   (United Kingdom)

^b ROYAL UNITED HOSPITAL   (United Kingdom)

Author keywords

Ingram treatment; Psoriasis; Quality of life; Validity; WHOQOL

Indexed keywords

ANTIPSORIASIS AGENT; DITHRANOL; EMOLLIENT AGENT; PSORALEN; TAR;

ADULT; AGED; ARTICLE; BODY IMAGE; CLINICAL PROTOCOL; COGNITION; CONCURRENT VALIDITY; CONSTRUCT VALIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; GENERAL CONDITION IMPROVEMENT; HEALTH PROGRAM; HEALTH STATUS; HUMAN; INDEPENDENCE; INGRAM TREATMENT REGIMEN; INTERNAL CONSISTENCY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; OUTPATIENT CARE; PHOTOTHERAPY; PRIORITY JOURNAL; PROFILE OF MOOD STATES; PSORIASIS; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; RELIGION; SELF ESTEEM; SYSTEMIC THERAPY; ULTRAVIOLET A RADIATION; VALIDATION PROCESS; WHOQOL 100;

ADOLESCENT; ADULT; AFFECT; AMBULATORY CARE; BODY IMAGE; FEMALE; HEALTH STATUS INDICATORS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGRAM EVALUATION; PSORIASIS; PSYCHOMETRICS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SELF CONCEPT; SEVERITY OF ILLNESS INDEX;

EID: 33644856164     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.07045.x     Document Type: Article

References (40)

1. Ryan TJ Disability in dermatology Br J Hosp Med 1991 46 33 6
2. Ginsberg IH Link BG Feelings of stigmatisation in patients with psoriasis J Am Acad Dermatol 1989 20 53 63
3. Papadopoulos L Bor R Legg C Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive behaviour therapy Br J Med Psychol 1999 72 382 96
4. Mukhtar R Choi J Koo JY Quality of life issues in psoriasis Dermatol Clin 2004 22 389 95
5. Koo J Population based epidemiological study of psoriasis with emphasis on quality of life assessment Psychodermatol 1996 14 485 96
6. Kurwa HA Finlay AY Dermatology inpatient management greatly improves life quality J Dermatol 1995 133 575 8
7. Finlay AY Khan GK Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use Clin Exp Dermatol 1994 19 210 16
8. Finlay AY Coles EC The effects of severe psoriasis on the quality of life of patients Br J Dermatol 1995 132 236 44
9. Rapp SR Feldman SR The promise and challenge of new biological treatments for psoriasis: how do they impact quality of life? Dermatol Ther 2004 17 376 82
10. Gelfand JM Feldman SR Stern RS et al. Determinants of quality of life in patients with psoriasis: a study from the US population J Am Acad Dermatol 2004 51 704 8
11. Zachariae R Zachariae C Ibsen HH et al. Psychological symptoms and quality of life of dermatology outpatients and hospitalized dermatology patients Acta Derm Venereol 2004 84 205 12
12. Jobling RG Psoriasis: a preliminary questionnaire study of sufferer's subjective experience Clin Exp Dermatol 1976 1 233 6
13. Ramsey B O'Reagan M A survey of the social and psychological effects of psoriasis Br J Dermatol 1988 118 195 201
14. Fried RG Trivial or terrible? The psychosocial impact of psoriasis Int J Dermatol 1995 34 101 5
15. Richards HL Fortune DG Weidmann A et al. Detection of psychological distress in patients with psoriasis: low consensus between dermatologist and patient Br J Dermatol 2004 151 1227 33
16. Finlay AY Khan GK Luscombe DK Salek MS Validation of the SIP and PDI, in psoriasis Br J Dermatol 1990 123 751 6
17. Sampogna F Sera F Abedna D and the IDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) investigators. Measures of clinical severity, quality of life and psychological distress in patients with psoriasis: a cluster analysis J Invest Dermatol 2004 122 602 7
18. Wessley SC Lewis GH The classification of psychiatric morbidity in attendees at dermatology clinic Br J Psychiatry 1989 155 686 91
19. Gupta MA Gupta AK Kirkby S et al. A psychocutaneous profile of psoriasis patients who are stress reactors. A study of 127 patients General Hosp Psychiatry 1989 11 166 73
20. Feldman SR Menter A Koo JY Improved health-related quality of life following a randomized controlled trial of alefacept treatment in patients with chronic plaque psoriasis Br J Dermatol 2004 150 317 26
21. Ganemo A Sjoden PO Johansson E et al. Health-related quality of life among patients with ichthyosis Eur J Dermatol 2004 14 61 6
22. Mckenna SP Doward LC Niero M Erdman R Development of needs-based quality of life instruments Value Health 2004 7 S17 21
23. Taylor WJ Assessment of outcome in psoriatic arthritis Curr Opin Rheumatol 2004 16 350 6
24. The WHOQOL Group. Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL) Qual Life Res 1993 2 153 9
25. The WHOQOL Group. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization Soc Sci Med 1995 41 1403 9
26. The WHOQOL Group. The World Health Organization Quality of Life assessment (WHOQOL): development and general psychometric properties Soc Sci Med 1998 46 1569 85
27. The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF Quality of Life assessment Psychol Med 1998 28 551 8
28. The WHOQOL Group. Development of the WHOQOL: rationale and current status Int J Ment Health 1994 23 24 56
29. Skevington SM Measuring quality of life in Britain: introducing the WHOQOL-100 J Psychosom Res 1999 47 449 59
30. Skevington SM Bradshaw J Saxena S Selecting national items for the WHOQOL: conceptual and psychometric considerations Soc Sci Med 1999 48 473 87
31. Szabo S on behalf of the WHOQOL Group. The World Health Organization Quality of Life (WHOQOL) Assessment Instrument. In: Quality of Life and Pharmacoeconomics in Clinical Trials Spilker B, ed.) 2nd edn Philadelphia, New York Lippincott-Raven Publishers 1996 355 62
32. Ware JE Snow KK Kosinski M et al. SF-36 Health Survey: Manual and Interpretation Guide Boston Boston Health Institute, New England Medical Center 1993
33. Ware JE Sherbourne CD The MOS 36 item short-form health survey (SF-36). I. Conceptual framework and item selection Med Care 1992 30 473 83
34. Ware JE Kosinski M Keller S SF-36 Physical and Mental Health Summary Scale: A User's Manual Boston The Health Institute, New England Medical Center 1994
35. Skevington SM Wright A Changes in the quality of life of patients receiving anti-depressant medication in primary care: validating the WHOQOL-100 Br J Psychiatry 2001 178 261 7
36. Streiner DL Norman GR Health Measurement Scales: A Practical Guide to their Development and Use 2nd edn Oxford Oxford University Press 1995
37. Skevington SM Lotfy M O'Connell K for the WHOQOL Group. The World Health Organization WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial Qual Life Res 2004 13 299 310
38. Skevington SM Advancing cross-cultural research on quality of life Qual Life Res 2002 11 135 44
39. Salek MS Finlay AY Lewis JJC Sumner MI Quality of life of cyclosporin in treatment of psoriasis with intermittent short course cyclosporin (Neoral) Qual Life Res 2004 13 91 5
40. Finlay AY Salek MS Haney J for the Alefacept Clinical Study Group. Intramuscular alefacept improves health-related quality of life in patients with chronic plaque psoriasis Dermatol 2003 206 307 15